A Study to Investigate the Safety and PK of VH4770359 in Healthy Participants

by palligoelme@gmail.com | Apr 13, 2026 | Clinical Trials

​ Conditions: HIV Infections Interventions: Drug: VH4770359; Drug: Placebo; Drug: Midazolam Sponsors: ViiV Healthcare Not yet recruiting Conditions: HIV Infections Interventions: Drug: VH4770359; Drug: Placebo; Drug: Midazolam Sponsors: ViiV Healthcare Not yet...

Pomalidomide, Anti-PD-1 Antibody Combined With Selinexor (PPS) in Relapsed/Refractory Primary Central Nervous System Diffuse Large B-Cell Lymphoma

by palligoelme@gmail.com | Apr 13, 2026 | Clinical Trials

​ Conditions: Primary Central Nervous System Lymphoma (PCNSL); Diffuse Large B Cell Lymphoma (DLBCL) Interventions: Drug: Pomalidomide; Drug: PD-1 / PD-L1 monoclonal antibody; Drug: XPO1 inhibitor Sponsors: Beijing Tongren Hospital Recruiting Conditions: Primary...

Physiological Safety and Behavioral Comfort of Swaddle Bathing in Preterm Infants

by palligoelme@gmail.com | Apr 13, 2026 | Clinical Trials

​ Conditions: Preterm Infants Interventions: Other: Swaddle Bathing; Other: Conventional Tub Bathing Sponsors: Chang Gung University of Science and Technology Recruiting Conditions: Preterm Infants Interventions: Other: Swaddle Bathing; Other: Conventional Tub Bathing...

Neurophysiological Markers for Prediction of Rehabilitation Outcomes After Ischemic Stroke

by palligoelme@gmail.com | Apr 9, 2026 | Clinical Trials

​ Conditions: Ischemic Stroke; Upper Limb Motor Impairment Interventions: Device: Intermittent Theta Burst Stimulation; Device: Sham Intermittent Theta Burst Stimulation Sponsors: Moscow Scientific and Practical Center of Medical Rehabilitation, Restorative and Sports...

Biomarkers for Predicting Mortality in Patients With Suspected Sepsis

by palligoelme@gmail.com | Apr 9, 2026 | Clinical Trials

​ Conditions: Sepsis; Mortality; Biomarkers Sponsors: Antalya Training and Research Hospital Completed Conditions: Sepsis; Mortality; Biomarkers Sponsors: Antalya Training and Research Hospital Completed